![]() COVID-19 infection also places children at risk of developing long-term complications like multisystem inflammatory syndrome, which can lead to life-threatening problems in the heart and other bodily organs. Since the beginning of the pandemic more than 8,300 children ages 5 to 11 have been hospitalized for COVID-19, the majority of whom had an underlying condition such as asthma. When reported, the cases have especially been in adolescents and young adult males within several days after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna). Pfizer researchers recorded no cases of myocarditis among 5- to 11-year-olds, which was to be expected given the study’s small size and the rarity of the condition, but that age group also generally sees lower instances of myocarditis compared with the rest of the population.Ĭhildren between the ages of 5 to 11 account for around 40% of all pediatric COVID-19 cases, one of the highest case rates of all age groups. Shortness of breath Feelings of having a fast-beating, fluttering, or pounding heart Myocarditis and pericarditis have rarely been reported. Nearly all of these vaccine recipients have recovered quickly without any lingering concerns. The highest-risk group comprises males ages 16 and 17, but even then the case rate is 0.007%. As Fortune has previously reported, there have been 877 cases of myocarditis out of more than 3.5 million vaccine doses given, according to the Vaccine Adverse Event Reporting System (VAERS). Symptoms often include chest pain, shortness of breath, or an abnormal heartbeat. One side effect that did not occur during the clinical trial was myocarditis, inflammation of the heart muscle, an extremely rare but serious side effect. There were no serious side effects related to the vaccine. Vaccine side effects can be lumped into three major categories: Mild such as body ache and soreness in the arm, moderate such as headache and severe that may cause shortness of breath. Fewer than 10% of children experienced fever, chills, and muscle pain. ![]() Fatigue and headaches were reported at significantly lower frequencies than by adolescents and adults: 39% of young children experienced fatigue, and 28% reported headaches, compared with 65% and 61% of trial participants ages 16 to 25. COVID-19 signs and symptoms include cough, shortness of breath. Pfizer stated that the lower dosage would reduce the frequency of side effects that were seen in older age groups while still providing a strong immune response for children.Īccording to a briefing document submitted by the company to the FDA, the most common side effect after the second dose was pain at the injection site for around 70% of children. Possible side effects are normal signs that your bodys immune system is responding to. ![]() The side effects were also milder and less frequent for the 2,268 kids in Pfizer’s clinical trial. In general, side effects were less common for children ages 5 to 11 than for adolescents and young adults.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |